SCPX (Scorpius Holdings) Tariff Resilience Score: 5/10 (As of Jul. 02, 2026)


What is Scorpius Holdings Tariff Resilience Score?

Scorpius Holdings SCPX -15.38% Tariff Resilience Score is 5 as of Jul. 02, 2026. The stock has 7 warning signs investors should review. Among 1,374 Biotechnology companies, Scorpius Holdings ranks better than 62.23% on this metric.

Scorpius Holdings has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Scorpius Holdings has Moderate exposure due to global supply chain dependencies. Manufacturing and sales are international, increasing vulnerability. Historical tariffs have impacted costs. Some mitigation through alternative suppliers, but limited pricing flexibility.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Scorpius Holdings might have Average Resilient.

Scorpius Holdings  (OTCPK:SCPX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Scorpius Holdings Tariff Resilience Score Related Terms

SCPX vs CARM, CYTOF, CNBX: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Scorpius Holdings's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scorpius Holdings Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scorpius Holdings's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Scorpius Holdings's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
Scorpius Holdings (SCPX) has a Tariff Resilience Score of 5 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Scorpius Holdings ranks #519 out of 1374 companies in the Biotechnology industry, placing it in the top 37.8%.
Is Scorpius Holdings' Tariff Resilience Score too high?
Scorpius Holdings' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Scorpius Holdings' value of 5 is 25% above this industry median. Based on the distribution chart, Scorpius Holdings ranks #519 out of 1374 companies in the Biotechnology industry, which is above the industry midpoint.
How does Scorpius Holdings' Tariff Resilience Score compare to CARM and CYTOF?
According to the Biotechnology industry distribution chart, Scorpius Holdings ranks #519 out of 1374 companies for Tariff Resilience Score. This puts Scorpius Holdings in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Scorpius Holdings' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scorpius Holdings's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scorpius Holdings's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scorpius Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scorpius Holdings (SCPX) is currently considered Possible Value Trap. The stock's GF Value™ is $0.14, compared to a current price of $0.00 — trading 99.2% below its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Scorpius Holdings (SCPX), the current Tariff Resilience Score is 5 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scorpius Holdings Business Description

Address 1305 East Houston Street, San Antonio, TX, USA, 27560
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state of the art facilities.